Last update Nov. 11, 2020

Diloxanide Furoate

Low Risk

Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

Intra-lumen amebicide drug that is used alone or in combination with Metronidazole.
Oral administration 3 times a day for 10 days.

Since the last update we have not found any published data on its excretion in breast milk.

The paucity of available pharmacokinetic data (Drug 2020, CECMED 2015) does not allow predicting the amount of its possible excretion in human milk.

A mild side effect like flatulence observed among treated patients does not represent any risk for the child. No untoward effect on infants has been reported.

It may be given to children from the age of 1 month (BNF 2019 p325).

It is considered an essential medicine by the WHO (WHO 2002).


We do not have alternatives for Diloxanide Furoate.

Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Diloxanide Furoate in other languages or writings:


Diloxanide Furoate belongs to this group or family:


Main tradenames from several countries containing Diloxanide Furoate in its composition:


Variable Value Unit
Oral Bioavail. 90 %
Molecular weight 328 daltons
pKa 9.39 -
Tmax 1 - 2 hours
3 - 6 hours


  1. Diloxanide. Drug Summary. 2020 Full text (in our servers)
  2. BNF. British National Formulary for Children 2018-2019 2018
  3. CECMED. Diloxanida. Ficha técnica. 2015 Full text (in our servers)
  4. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Abstract Full text (link to original source) Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at

e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) of Mexico

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM